Syros Pharmaceuticals, Inc., a biopharmaceutical company, is focused on developing treatments for cancer and single-gene diseases and building a line of gene-driven drugs. The company’s lead product candidates are SY-1425, a selective retinoic acid receptor alpha agonist, which is in a phase II clinical trial for a genomically defined subset of patients with acute myeloid leukemia and a phase III clinical trial for patients with myelodysplastic syndrome; SY-5609, a cyclin-dependent kinase 7 inhibitor, which is in a phase I clinical trial in patients with selected advanced solid tumors; and SY-2101, a new oral form of arsenic trioxide for the treatment of patients with acute promyelocytic leukemia. Has target discovery, research collaboration, and option agreement with Incyte Corporation to identify therapeutic targets with a focus on myeloproliferative neoplasms; and a license agreement with TMRC Co. Ltd. for the development and commercialization of tamibarotene. The company was previously known as LS22, Inc. and changed its name to Syros Pharmaceuticals, Inc. in August 2012. Syros Pharmaceuticals, Inc. was founded in 2011 and is headquartered in Cambridge, Massachusetts.
You want to learn how to buy Syros Pharmaceuticals (SYRS) shares, Guide
Are you interested in buying Syros Pharmaceuticals (SYRS) shares on Nasdaq reliably and using a regulated broker in Europe? Does it strike you to be able to make your profits profitable each month and make profits on the stock market? Today I am going to show you how you can register with DeGiro , a reliable German investment broker with low commissions, and how you can get your first Syros Pharmaceuticals, Inc. (SYRS) (SYRS) share quickly and intuitively. .
The method to follow is easy to carry out :
- To begin with, we are going to register in DEGIRO, an interface in which we will invest in shares of Syros Pharmaceuticals, Inc. (SYRS) (SYRS).
- In 2nd place we will add funds to carry out the 1st investment.
- Once we see the funds we have to look for Syros Pharmaceuticals through the ticker, which is SYRS.
- To finish, we only have to indicate the number of shares that we will buy, the purchase price and the type of order.
Perhaps this tutorial has been basic for you, so now you are going to see the whole process with images.
How to register in degiro.
As a first step we will register in degiro with this link :
It will ask us for an email, a username and a password to enter, and then we must continue using the link that they have sent us by email address.
degiro will continually ask us for some information of interest to corroborate that it is us . We must have at hand our passport number, DNI (identity document) or driving license, our mobile phone and the number of the bank account that we will place to make our 1st deposit. If you have no idea what this format is, you can check this simple guide article that we wrote at Educacep .
Once our account is approved we can put money from the Deposit / Withdraw section. We will be able to make a bank transfer that will take between 1-2 days, or proceed to make the deposit quickly using Sofort, a completely secure and very reliable payment gateway.
How to buy Syros Pharmaceuticals (SYRS) shares through DEGIRO
When we finally have the capital we have the possibility of investing in our first action. You can select the “Place order” button that you will find in the upper right corner or select the spin search engine and write the ticker. In the next image you will find that I have put the Amazon ticker but in your case you should enter (SYRS), the Syros Pharmaceuticals ticker. As we are talking about an action, we will discover that related businesses and companies are listed and there we will discover to find Syros Pharmaceuticals. The fundamental thing is that the ticker, the name of the company and the market in which it is listed coincide. Amazon is listed on NASDAQ (NDQ) and in your case Syros Pharmaceuticals, Inc. (SYRS) is listed on Nasdaq. This step is very essential so do not make a mistake.
At the time of placing the order we will have to pay close attention to what I am going to explain to you . We will have the possibility of placing a limit or market order. Imagine that you plan to buy a share of Syros Pharmaceuticals at 6.01, but its actual price is higher. With a limit order we will put the value at which we calculate to carry out the operation and until there are no shares for sale at that price, the purchase operation of the share will not be executed. With a market order DeGiro will buy the number of shares that we have adjusted to the true selling price, which will be very close to the current trading price.
In all cases it is very essential that you look at the type of order: fixed or of the day . For example, in Spain, the stock market is in the morning and until 1 in the afternoon, and in the USA it corresponds to the afternoon schedule in Spain. If the order is permanent, it will last until the point where it can be executed, but if you select the “of the day” option, at the end of the day, if it is not executed, it will be removed from your Activity panel – Pending Orders .
I would like this short text to help you buy shares in Syros Pharmaceuticals. Until another!
|Name||Title||Payment||exercised||Year of birth|
|Dr. Nancy A. Simonian||President, CEO and Director||897.05k||N/A||1961|
|Dr. Richard A. Young||Scientific founder, member of the scientific advisory board and director||165k||N/A||1954|
|Eric R. Olson, MD||Scientific Director||638.63k||N/A||1958|
|Dr. David A. Roth||Medical director||641.48k||N/A||1963|
|Dr. James E. Bradner||Founder||N/A||N/A||1972|
|Dr. Nathanael S. Gray Ph.D.||Scientific founder and member of the Scientific Advisory Board||N/A||N/A||N/A|
|Mr. Joseph J. Ferra Jr.||CFO and Treasurer||N/A||N/A||1976|
|Mr. Gerald E. Quirk||Legal and Administrative Head. Officer and Sec.||N/A||N/A||1968|
|Mrs Naomi Aoki||Vice President of Corporate Communications and Investor Relations||N/A||N/A||N/A|
|Dr. Christian C. Fritz||Head of Biology||N/A||N/A||N/A|
Syros Pharmaceuticals recent events:
Recent Events June 12, 2020 Complete 8-K Filed: Submission of Matters to Securityholder Vote May 07, 2020 Complete 10-Q Filed: Quarterly ReportMar 05, 2020 Complete 10-K: Annual Report February 13 Filed January 13, 2020 Filed Full 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Fine January 13, 2020 Filed Full 8-K: Disclosure of Regulation FD, Other Events, Financial Statements and Exhibits